Curaleaf PolandS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-01-02
Share capital
100 000,00 PLN
Activity description

Curaleaf Poland is a licensed pharmaceutical wholesaler specializing in the acquisition, registration, and distribution of medical cannabis products for prescription use. The company provides pharmacies with access to a range of cannabis-based medicines, including dried and extract products containing THC and cannabinoids, all manufactured under GMP conditions. Curaleaf Poland focuses on expanding patient access to high-quality medical cannabis in the growing market since its legalization in 2017.

Registered address
ul. Walońska 17/1, 50-413 Wrocław, Poland
Website
can4med.plWebsite active
Phone
Social media
Electronic delivery address
AE:PL-70253-75717-FEHIV-16

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.81mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 138.16kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 3.58mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 2.61mMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 2019-12-24. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Jan 18, 2023Transformation

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,131

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Arkadiusz Zbigniew Piotrowicz — President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by the President of the Management Board. In the case of a management board consisting of two or more members, declarations of will on behalf of the company may be made by the President of the Management Board or the Vice-President of the Management Board independently, or joint action by a member of the management board together with a commercial proxy is required.

Supervisory board

Georg Andreas Weinberg — Supervisory Board Member
Christiane Weinberg — Supervisory Board Member
Maximilian Weinberg — Supervisory Board Member

Ownership

Owner
Curaleaf International Limited

Beneficial owners

Person
Boris Alexis Jordan (60)

Competitors

Name
Euroleki Gksp. z o.o. + limited partnership
Bestpharmasp. z o.o.
CarnexS.K.A.
Imarti Poland sp. z o.o.sp. k.
Polska Grupa Farmaceutycznasp. z o.o.
Steriwundsp. z o.o.
Farmbudsp. z o.o.
Vente Amicalesp. z o.o.
PUBE Globalsp. z o.o.
Passimedsp. z o.o.

Change history

DateEvent
2024-08-22Name change
2023-01-02Entered in the register

FAQ

Last updated: 2026-07-31